January 26, 2023
Aspiring to deliver new cures for complex conditions
Mayo Clinic is building toward a future when biologics can cure cancer, kidney disease and diabetes. Mayo marks 2022 as a year of significant strides in accelerating science to make and deliver regenerative biotherapeutics. The goal is to offer new options, based on rigorous research in cell and gene therapies, for disorders with few available […]
Tags: 3D bioprinting, biologics, biomanufacturing, CAR-T cell therapy, Center for Regenerative Biotherapeutics, Julie Allickson, purified exosome product, stromal vascular fraction cells, tissue engineering
January 10, 2023
Mayo Clinic opens a second Regenerative Medicine Therapeutic Suites
Mayo Clinic has opened the Regenerative Medicine Therapeutic Suites in Arizona for patients seeking enhanced care when standard procedures don’t meet their needs. The suites are an intersection of clinical practice, research and lab space where patients can have their cells processed on-site for immediate application to their condition. “It’s a whole new level of […]
Tags: bone marrow aspirate concentrate, Center for Regenerative Biotherapeutics, David Lott, platelet rich plasma, Regenerative Medicine Therapeutic Suites, stromal vascular fraction cells, tissue engineering